Ayelet Dilion-Mashiah

MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD.

Theraclone Sciences, Inc. develops novel therapeutic antibodies for the treatment of cancer and infectious diseases. The firm leverages its proprietary antibody discovery technology, I-STARTM to identify rare fully human antibodies from immunologically relevant human subjects. The firm’s primary research focus is to discover novel targets and antibodies, and develop therapeutic monoclonal antibodies, by using its proprietary B-cell technology platform to mine the immune system of cancer patients. The company was founded by Johnny T. Stine in November 2004 and is headquartered in Seattle, WA.

ZyVersa Therapeutics Operating, Inc. operates as a specialty pharmaceutical company, which develops and commercializes prescription pharmaceutical products. The firm focuses on developing products for the treatment of men?s health, as well as for other markets where current therapies are suboptimal and underdeveloped. It offers VAR 100, an oral formulation of native testosterone to treat male hypogonadism; and VAR 200 that minimizes and prevents kidney cell damage, and improves focal segmental glomerulosclerosis prognosis. The company was founded by Stephen C. Glover and Shawn M. Titcomb in 2014 and is headquartered in Weston, FL.

Jefferies LLC is a global investment bank and institutional securities firm headquartered in New York City. The firm was founded in 1962 and is a subsidiary of Jefferies Group LLC, ultimately held by Jefferies Financial Group, Inc. (NYSE: JEF). Jefferies provides corporate clients with research and execution services in equity, fixed income, and foreign exchange markets, as well as a full range of investment banking services such as underwriting, mergers and acquisitions, restructuring and recapitalization, and other advisory services, with all businesses operating in the Americas, Europe and Asia.

Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY.

The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY.

Lev Pharmaceuticals, Inc. develops and commercializes therapeutic products for the treatment of inflammatory diseases. It researches a series of drugs to fight both edema and heart attacks. The company is located in New York.

UnitedHealthcare of Georgia, Inc. provides health insurance products and services. The firm offers dental, disability, health, and life insurance services. It serves individual consumers, employers, governments, commercial payers and intermediaries. The company is headquartered in Norcross, GA.

DSIT Solutions Ltd. develops underwater security, sonar and acoustics systems. It offers underwater security, acoustic analysis, anti-submarine warfare systems, and sonar simulation solutions to the commercial, energy, defense, and homeland security markets. The company was founded in 1993 and is headquartered in Givat Shmuel, Israel

Part of American Bank, Inc., American Bank (Allentown, PA) is a financial institution that reflects the goals and aspirations of its customers. The company offers a range of products and services and provides personalized customer care. Mark W. Jaindl has been the CEO of the company since 1997.

ADMA Plasma Biologics, Inc. develops medicines for the treatment of infectious diseases. The company was founded in 2007 and is headquartered in Hackensack, NJ.

Tyrogenex, Inc. operates as a biopharmaceutical company which develops dual vascular endothelial growth factor receptor and platelet-derived growth factor receptor inhibitors for wet age-related macular degeneration and solid tumors. Its compound targets the basic mechanisms of neovascular eye diseases, including angiogenesis, fibrosis and inflammation. The company was founded by Chris Liang, Teri Ardleigh Swift, and Sheridan G. Snyder and is headquartered in Rockville, MD.

In 1998, OmniMetrix introduced the first wireless remote monitor for on-site power generation - a truly innovative product at that time. Since then, demand for wireless monitors has skyrocketed as consumers worldwide have begun to rely on the continuous stream of valuable information contained within their gensets. OmniMetrix has remained the leader in this industry by finding innovative ways to help customers meet their on-site power and standby power needs. OmniMetrix provides expert capabilities in the design and development of wireless field devices and internet-connected data management systems. This includes microprocessor-based, miniature, on-machine field equipment, fully redundant SQL-based data management, and web-delivered equipment status pages. While most OmniMetrix systems are used in electric power applications, they also build systems for Corrosion Prevention and Pipeline Monitoring.

Labconnect Holdings, Inc. engages in providing laboratory services which include routine and esoteric laboratory testing, kit building, sample management, biorepository and scientific support services for biopharmaceutical. The company is headquartered in Seattle, WA.

Verimmune, Inc. is a company based in Washington that is dedicated to developing a first-in-class cancer immunotherapy called anti-tumor immune redirection (AIR). Verimmune's proprietary virus-inspired particle (VIP) technology platform redirects pre-existing pathogenic or childhood vaccine immune memory toward tumors. The American company's lead immuno-oncology product candidate, Veri-101, harnesses the cellular immune memory responses from prior cytomegalovirus (CMV) infection to fight cancer. This mechanism of action has the potential to redefine the treatment paradigm for patients with untreatable cancers or resistance to existing therapies. The company was founded in 1995 by John Troyer and Joshua Weiyuan Wang, with Joshua Weiyuan Wang serving as the CEO since then.

NewStem Ltd. is an Israeli company that aims to revolutionize the life sciences industry and the development of therapeutics and diagnostics. The company is based in Givat Ram, Israel. The company has a deep understanding of human stem cells and use their proprietary technology of haploid human embryonic stem cells to achieve their goals. The company was founded in 2016 by Nissim Benvenisty. The CEO is Ayelet Dilion Mashiah.